Mr. Andre Larente reports

DIAGNOS PROVIDES UPDATE ON ITS HEALTH CANADA MEDICAL DEVICE LICENCE APPLICATION

Diagnos Inc. has provided an update on the progress of its medical device licence application for the Cara system, submitted to Health Canada in early September, 2024.

Following the submission of its application in early September, Diagnos has engaged in continuing communication with Health Canada, providing timely responses to all regulatory requests. After more than 11 pro-active inquiries regarding the application's status, Diagnos is pleased to announce that Health Canada has confirmed that the application is now under active processing, having progressed from a previous backlog.

"We remain steadfast to complying with all regulatory requirements and ensuring that Health Canada has all the necessary information to support the review of our Cara system application," said Andre Larente, chief executive officer of Diagnos. "We appreciate the continued collaboration with Health Canada and are optimistic about the future progress of our application."

Diagnos is dedicated to advancing its mission of providing cutting-edge medical diagnostic solutions, and the Cara system is a key part of the company's growth strategy.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging artificial intelligence, Diagnos aims to provide more information to health care clinicians to enhance diagnostic accuracy, streamline workflows and improve patient outcomes on a global scale.